Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide plus chemotherapy in advanced breast cancer
NCT02649101Phase 2Unknown
- Sponsor
- Zhejiang Cancer Hospital
- Start
- Oct 2015
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thalidomide in breast cancer, sponsored by Zhejiang Cancer Hospital. Status: unknown.
02
Drugs
thalidomide
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02649101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02649101.